We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101).
- Authors
Futoshi Kunieda; Takahiro Kasamatsu; Takahide Arimoto; Takashi Onda; Takafumi Toita; Taro Shibata; Haruhiko Fukuda; Toshiharu Kamura
- Abstract
A non-randomized confirmatory trial was started in Japan to evaluate the efficacy of modified radical hysterectomy in patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer, for which the current standard is radical hysterectomy. This study began in January 2013 and a total of 240 patients will be accrued from 37 institutions within 3 years. The primary endpoint is 5-year survival. The secondary endpoints are overall survival, relapse-free survival, local relapse-free survival, percent completion of modified radical hysterectomy, percent local relapse, percent pathological parametrial involvement, days until self-urination and residual urine disappearance, blood loss, operation time, percent post-operative radiation therapy, adverse events and severe adverse events
- Publication
Japanese Journal of Clinical Oncology, 2015, Vol 45, Issue 1, p123
- ISSN
0368-2811
- Publication type
Article
- DOI
10.1093/jjco/hyu168